G
Goldline Pharmaceutical Ltd.
SMEListedListed on 19 May 2026+39.0%
Price Range
₹41–43
Issue Size
₹ 8 Cr
Lot Size
6000 Shares
Min. Investment
₹ 2,46,000
Historical Financials
Annual consolidated / standalone figures
| Particulars | FY 2022-23 | FY 2023-24 | FY 2024-25 |
|---|---|---|---|
| Operating Revenue (₹ Cr) | 1,984.84 | 2,356.6 | 2,805.57 |
| Other Income (₹ Cr) | 0.01 | 0 | 0 |
| Total Income (₹ Cr) | 1,984.85 | 2,356.6 | 2,805.57 |
| Total Expenses (₹ Cr) | 1,763.84 | 1,926.18 | 2,199.98 |
| Profit Before Tax (₹ Cr) | 40.14 | 252.69 | 385.84 |
| PAT (₹ Cr) | 25.66 | 180.6 | 283.42 |
| Net Worth (₹ Cr) | 589.04 | 786.54 | 1,035.34 |
| Borrowings (₹ Cr) | 0 | 0 | 0 |
| EPS (₹) | 0.43 | 3.01 | 4.11 |
| ROE (%) | 6.28 | 35.62 | 38.81 |